Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis

American Journal of Obstetrics and Gynecology

Volumn 191, Issue 3, 2004, Pages 733-740

  Modugno, Francesmary ^a,b   Ness, Roberta B ^a   Allen, Glenn O ^a   Schildkraut, Joellen M ^a   Davis, Faith G ^a   Goodman, Marc T ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Endometriosis; Estrogen; Oral contraceptive; Ovarian cancer

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ANALYTIC METHOD; ANAMNESIS; ARTICLE; BREAST FEEDING; CALCULATION; CANCER INCIDENCE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG UTILIZATION; ENDOMETRIOSIS; EPITHELIAL OVARIAN CANCER; FAMILY HISTORY; FEMALE; GYNECOLOGIC SURGERY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVARY CANCER; PARITY; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SELF REPORT; SURGICAL TECHNIQUE; UTERINE TUBE LIGATION;

ADULT; AGED; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; ENDOMETRIOSIS; FEMALE; HUMANS; HYSTERECTOMY; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; PREGNANCY; REPRODUCTION; RISK FACTORS; STERILIZATION, TUBAL;

EID: 4644254069     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.03.035     Document Type: Article

References (34)

1. Ballweg M.L. The endometriosis sourcebook. 1999;The Endometriosis Association, Milwaukee (WI)
2. Vignali M., Infantino M., Matrone R., Chiodo I., Somigliana E., Busacca M., et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril. 78:2002;665-678
3. Brinton L.A., Gridley G., Persson I., Baron J., Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 176:1997;572-579
4. Sinaii N., Cleary S.D., Ballweg M.L., Nieman L.K., Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod. 17:2002;2715-2724
5. American Cancer Society. American Cancer Society facts and figures 2003. 2003;American Cancer Society, Washington (DC). p. 1-52
6. Heintz A.P., Odicino F., Maisonneuve P., Beller U., Benedet J.L., Creasman W.T., et al. Carcinoma of the ovary. J Epidemiol Biostat. 6:2001;107-138
7. Whittemore A.S., Harris R., Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies: II, invasive epithelial ovarian cancers in white women: Collaborative Ovarian Cancer Group. Am J Epidemiol. 136:1992;1184-1203
8. Rosenblatt K.A., Thomas D.B. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy: the World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev. 5:1996;933-935
9. Gwinn M.L., Lee N.C., Rhodes P.H., Layde P.M., Rubin G.L. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol. 43:1990;559-568
10. Ness R.B., Grisso J., Klapper J., Schlesselman J.J., Silverzweig S., Vergona R., et al., the SHARE Study Group. Risk of ovarian cancer in relation to estrogen dose and use characteristics of oral contraceptives. Am J Epidemiol. 152:2000;233-241
11. Goodman M.T., Wu A.H., Tung K.H., McDuffie K., Cramer D.W., Wilkens L.R., et al. Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer. Am J Epidemiol. 156:2002;693-701
12. Moorman P.G., Schildkraut J.M., Calingaert B., Halabi S., Vine M.F., Berchuck A. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States). Cancer Causes Control. 13:2002;807-811
13. Kupelian V, Davis F, Mallin K, Rosenblatt K. Tubal sterilization, hysterectomy and risk of ovarian cancer: a case-control study [Abstract 273]. Presented at SER Seattle, June 2000. Am J Epidemiol 2000;151:S69.
14. Breslow N.E., Day N.E. Statistical methods in cancer research. 32 ed. :1980;IARC Scientific Publications, Lyon, France
15. Ness R.B., Cramer D.W., Goodman M.T., Kjaer S.K., Mallin K., Mosgaard B.J., et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol. 155:2002;217-224
16. Elsheikh A., Milingos S., Loutradis D., Kallipolitis G., Michalas S. Endometriosis and reproductive disorders. Ann NY Acad Sci. 997:2003;247-254
17. Cottreau C.M., Ness R.B., Modugno F., Allen G.O., Goodman M.T. Endometriosis and its treatment with danazol or Lupron in relation to ovarian cancer. Clin Cancer Res. 9:2003;5142-5144
18. Cramer D.W., Missmer S.A. The epidemiology of endometriosis. Ann NY Acad Sci. 955:2002;11-22
19. Risch H.A. Hormonal etiology of epithelial ovarian cancer, with hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 90:1998;1774-1786
20. Ness R.B. Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol. 189:2003;280-294
21. Vessey M.P., Villard-Mackintosh L., Painter R. Epidemiology of endometriosis in women attending family planning clinics. BMJ. 306:1993;182-184
22. Signorello L.B., Harlow B.L., Cramer D.W., Spiegelman D., Hill J.A. Epidemiologic determinants of endometriosis: a hospital-based case-control study. Ann Epidemiol. 7:1997;267-274
23. Parazzini F., Ferraroni M., Fedele L. Pelvic endometriosis: reproductive and menstrual risk factors at different stages in Lombardy, northern Italy. J Epidemiol. 49:1995;61-64
24. King R.J. Biology of female sex hormone action in relation to contraceptive agents and neoplasia. Contraception. 43:1991;527-542
25. Yen S.S. Endocrinology of pregnancy. Creasy R.K., Resnik R. Maternal-fetal medicine: principles and practice. 3rd ed. :1994;382-412 Saunders, Philadelphia
26. de la Cuesta R.S., Eichhorn J.H., Rice L.W., Fuller A.F., Nikrui N., Goff B.A. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol. 60:1996;238-244
27. Fukunaga M., Nomura K., Ishikawa E., Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology. 30:1997;249-255
28. McMeekin D.S., Burger R.A., Manetta A., DiSaia P., Berman M.L. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. Gynecol Oncol. 59:1998;81-86
29. Vercellini P., Parazzini F., Bolis G., Carinelli S., Dindelli M., Vendola N., et al. Endometriosis and ovarian cancer. Am J Obstet Gynecol. 169:1993;181-182
30. Modugno F., Ness R.B., Cottreau C.M. Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer. Epidemiology. 13:2002;467-471
31. Modugno F., Ness R.B., Allen G.O. Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer. Obstet Gynecol. 102:2003;1336-1343
32. Risch H.A., Marrett L.D., Jain M., Howe G.R. Differences in risk factors for epithelial ovarian cancer by histologic type: results of a case-control study. Am J Epidemiol. 144:1996;363-372
33. Purdie D.M., Webb P.M., Siskind V., Bain C.J., Green A.C. The different etiologies of mucinous and nonmucinous epithelial ovarian cancers. Gynecol Oncol. 88:(suppl):2003;S145-S148
34. Modugno F., Ness R.B., Wheeler J.E. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol. 11:2001;568-574